Economic aspects of chemotherapy

Area of Science:

• Oncology
• Health Economics

Background:

• A systematic review assessed chemotherapy's effect and health economics across various tumor types.
• Limited studies on chemotherapy's cost-effectiveness were available for review.

Purpose of the Study:

• To evaluate the cost-effectiveness of different chemotherapeutic regimens.
• To assess the economic impact of chemotherapy in Sweden.

Main Methods:

• Systematic review of international and Swedish studies.
• Analysis of cost-effectiveness data, comparing treatment costs with outcomes like life-years gained.

Main Results:

• Study quality is generally low, with limited comparability.
• Cost-effectiveness varies by treatment and indication; some regimens show cost savings.
• High-quality studies indicate a cost per quality-adjusted life-year gained between 100,000-250,000 SEK for many regimens.

Conclusions:

• Significant uncertainty exists regarding cost-effectiveness and reasonable costs per life-year gained.
• International findings are difficult to apply directly to Sweden.
• More Sweden-specific studies are needed for improved cost-effectiveness assessments.